Brief tamoxifen pretreatment enhances the chemosensitivity of gastric carcinoma cells to 5-fluorouracil in vitro

Anticancer Research

Volumn 23, Issue 2 B, 2003, Pages 1575-1580

  Koullias, George J ^a,f   Pratsinis, Charis I ^b   Korkolis, Dimitris P ^c   Kouraklis, Gregory ^d   Papadopoulos, Stylianos A ^e   Davaris, Panagiotis S ^b   Golematis, Basil Ch ^b  

^a Pinnacle Health System   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d LAIKO GENERAL HOSPITAL   (Greece)

^e HIPPOKRATION HOSPITAL   (Greece)

^f NONE   (United States)

Author keywords

Carcinoma cells; Chemotherapy; Gastric; Tamoxifen

Indexed keywords

CANCER GROWTH FACTOR; ESTROGEN RECEPTOR; FLUOROURACIL; TAMOXIFEN;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER CELL CULTURE; CARCINOMA CELL; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG POTENTIATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; PRIORITY JOURNAL; STOMACH CARCINOMA;

ACTIVIN RECEPTORS, TYPE I; ADENOCARCINOMA; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, HORMONAL; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, NEOPLASM; ESTRADIOL; FLUOROURACIL; HUMANS; NEOPLASM PROTEINS; PROTEOGLYCANS; RECEPTORS, ESTROGEN; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; STOMACH NEOPLASMS; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED;

EID: 0038238032     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Togunaga A, Kojima N, Andoh T et al.: Hormone receptors in gastric cancer. Eur J Cancer Clin Oncol 19: 687-9, 1983.
2. Koullias GJ, Kouraklis Gr, Papadopoulos A et al.: Increased estrogen and epidermal growth factor receptor gene product co-expression in surgically resected gastric adenocarcinomas. J Surg Oncol 63: 166-71.q, 1996.
3. Sica V, Nora E, Contieri E et al.: Estradiol and progesterone receptors in malignant gastrointestinal tumors. Cancer Res 44: 4670-74, 1984.
4. Tokunaga A, Nishi K, Matsukura N et al.: Estrogen and progesterone receptors in gastric cancer. Cancer 57: 1376-79, 1986.
5. Harrison JD, Morris DL and Ellis IO: The effect of tamoxifen and estrogen receptor status on survival in gastric carcinoma. Cancer 64: 1007-10, 1989.
6. Kojima O and Takahashi T: Endocrine therapy for shcirrous carcinoma of the stomach. Jpn J Cancer Chemother 10: 2453-60, 1983.
7. Kitaoka H: Sex hormone dependency and endocrine therapy for patients with diffuse carcinoma of the stomach. Jpn J Cancer Chemother 13: 2526-31, 1986.
8. Hosoya Y, Kitoh Y, Kobayashi E et al.: Combination effects of tamoxifen plus 5-fluorouracil on gastric cancer cells in vitro. Cancer Letters 140: 139-143, 1999.
9. Ramu A, Glaubiger D and Fuks D: Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analogues. Cancer Res 44: 4392-97, 1984.
10. Clarke R, van den Berg HW, Nelson J and Murphy RF: Pharmacological and suprapharmacological concentrations of both 17b estradiol (E2) and Tamoxifen (TAM) reduce the membrane fluidity of MCF-7 and MDA-MB-436 human breast cancer cells. Biochem Soc Trans 15: 243-49, 1987.
11. Higginson J and Gelmann E: Scientific review of Tamoxifen, 24 Seminars in Oncology (suppl 1) 2/1997.
12. Bermann E, Adams M, Duigou-Ostendorf R et al.: Effect of Tamoxifen on cell lines displaying the multidrug-resistant phenotype. Blood 77: 818-25, 1991.
13. Katner N, Riordan JR and Ling V: Cell surface P-glycoprotein is associated with multidrug resistance in mammalian cell lines. Science 221: 1285-89, 1983.
14. Kamivatari M, Nagat Y, Kikuchi H et al.: Correlation between reversing multidrug resistance and inhibiting of [3H] azidopine photolabeling of P-glycoprotein by newly synthesized dihydropyridine analogues. Cancer Res 49: 3190-5, 1989.
15. Colletta AA, Wakefield LM, Howell FV et al.: Antiestrogen induce the secretion of active Transforming Growth Factor β from human fetal fibroblasts. Br J Cancer 62: 402-9, 1990.
16. Jeng MH, P ten-Dijke, Iwata KK and Jordan VC: Regulation of the levels of three Transforming growth factor mRNA by estrogen and their effects on the proliferation of human breast cancer cells. Mol Cell Endocrinol 92: 115-23, 1993.
17. Pu-YS, Hsieh-TS, Tsai-TC et al.: Tamoxifen enhances the chemosensitivity of bladder carcinoma cells. J Urol 154(2 Pt-1): 601-5, 1995.